This article contains some figures that are displayed in color online but in black-and-white in the print edition.
Portions of this work were presented as an oral presentation at ASTRO's 54th Annual Meeting held in Boston, Massachusetts, on October 28–31, 2012.
Aoyama HShirato HOnimaru RKagei KIkeda JIshii N: Hypofractionated stereotactic radiotherapy alone without whole-brain irradiation for patients with solitary and oligo brain metastasis using noninvasive fixation of the skull. Int J Radiat Oncol Biol Phys 56:793–8002003
Lazow SPYondorf MKovanlikaya INori DChao KCBoockvar JA: Temporal changes in MRI edema and resection cavity dynamics subsequent to implantation of cesium-131 (Cs-131) brachytherapy in patients with brain metastases: a volumetric analysis from a prospective study. Int J Radiat Oncol Biol Phys 87:SupplS256–S2572013. (Abstract)
Linskey MEAndrews DWAsher ALBurri SHKondziolka DRobinson PD: The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 96:45–682010
Wernicke AGChao KSNori DParashar BYondorf MBoockvar JA: The cost-effectiveness of surgical resection plus cesium-131 (Cs-131) brachytherapy versus stereotactic radiosurgery versus surgery + whole brain radiotherapy (WBRT) versus WBRT in the treatment of metastatic brain tumors. Neuro Oncol 14:Suppl 6vi139–vi1412012. (Abstract)